Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Total Current Liabilities (2022 - 2025)

Praxis Precision Medicines (PRAX) has 4 years of Total Current Liabilities data on record, last reported at $59.8 million in Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 59.18% year-over-year to $59.8 million; the TTM value through Dec 2025 reached $59.8 million, up 59.18%, while the annual FY2025 figure was $59.8 million, 59.18% up from the prior year.
  • Total Current Liabilities reached $59.8 million in Q4 2025 per PRAX's latest filing, up from $52.9 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $59.8 million in Q4 2025 and bottomed at $15.7 million in Q4 2023.
  • Average Total Current Liabilities over 4 years is $33.7 million, with a median of $32.9 million recorded in 2024.
  • Peak YoY movement for Total Current Liabilities: crashed 54.14% in 2023, then skyrocketed 138.43% in 2024.
  • A 4-year view of Total Current Liabilities shows it stood at $34.3 million in 2022, then plummeted by 54.14% to $15.7 million in 2023, then surged by 138.43% to $37.6 million in 2024, then surged by 59.18% to $59.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $59.8 million in Q4 2025, $52.9 million in Q3 2025, and $48.6 million in Q2 2025.